Amanote Research
Register
Sign In
Targeted Combo Effective for Refractory Ewing Sarcoma
Cancer Discovery
- United States
doi 10.1158/2159-8290.cd-nb2012-035
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
April 2, 2012
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
Targeted Therapy in Ewing Sarcoma
ISRN Oncology
Tema 2-2014: Sarcoma De Ewing
Revista Clínica Escuela de Medicina UCR-HSJD
DNA Methylation Profiling Opens a New Phase in the Search of Targeted Therapy Against Ewing Sarcoma
Pharmacogenomics
Molecular Medicine
Genetics
Pharmacology
TTB2 Induces Apoptosis in Ewing Sarcoma Cells
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
BCL2/MDM2 Inhibitor Combo Effective in AML
Cancer Discovery
Oncology
A Combination CDK4/6 and IGF1R Inhibitor Strategy for Ewing Sarcoma
Clinical Cancer Research
Cancer Research
Oncology
Targeting Glutathione S-Transferase M4 in Ewing Sarcoma
Frontiers in Pediatrics
Child Health
Pediatrics
Perinatology
Drug Combo May Be Effective in Ovarian Cancer
Cancer Discovery
Oncology
Second Malignancies in Patients Treated for Ewing Sarcoma: A Systematic Review
Pediatric Blood and Cancer
Oncology
Child Health
Hematology
Perinatology
Medicine
Pediatrics